Brun Scott C. 的 Form 4 申報

Forte Biosciences, Inc.（FBRX），2026/8/27 申報

申報編號: 0001863614-26-000003
申報時間: 2026/8/27 16:34 ET
交易日: 2026/8/27
申報延遲: 當天
10b5-1 計畫: 沒有勾選

SEC EDGAR 原文（在新分頁開啟）

這份申報列了 5 筆衍生性交易。交易當天就申報。

申報人

一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人	與公司的關係
Brun Scott C.CIK 0001863614	董事

非衍生性證券（表 I）

普通股等股票的取得與處分，每一列是申報上的一筆。

這份申報沒有這一類的交易。

衍生性證券（表 II）

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日	證券	交易	標的股數	單價	金額	持有方式
2026/8/27	Common Stock	D交回公司處分	−2,000	–^F1,F2	–	直接
2026/8/27	Common Stock	D交回公司處分	−1,000	–^F1,F2	–	直接
2026/8/27	Common Stock	D交回公司處分	−2,000	–^F1,F2	–	直接
2026/8/27	Common Stock	D交回公司處分	−31,000	–^F1,F2	–	直接
2026/8/27	Common Stock	D交回公司處分	−18,353	–^F4	–	直接

附註與備註

本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。

Pursuant to the Agreement and Plan of Merger, dated July 26, 2026 (the "Merger Agreement"), by and among Forte Biosciences, Inc. ("Company"), argenx BV ("Parent"), and Avena Merger Sub Inc., a wholly owned subsidiary of Parent ("Purchaser"), each unexercised and outstanding option to purchase shares of Common Stock (a "Company Option"), whether or not vested, and which had a per share exercise price that was less than $77.00 per share ("Merger Consideration"), was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to Purchaser merging with and into Company (the "Merger"), with Company surviving the Merger as a wholly owned subsidiary of Parent.

表 II 有 4 筆交易的價格引用這則附註。

At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor.

表 II 有 4 筆交易的價格引用這則附註。

Pursuant to the Merger Agreement, each outstanding restricted stock unit (a "Company RSU"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger.

表 II 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文（在新分頁開啟）